keyword
MENU ▼
Read by QxMD icon Read
search

Prognosis cirrhosis

keyword
https://www.readbyqxmd.com/read/30328060/physical-activity-in-liver-transplantation-a-patient-s-and-physicians-experience
#1
Lara Beekman, Annalisa Berzigotti, Vanessa Banz
Liver transplantation has become a highly standardized, acceptable option for selected patients with end-stage liver disease and/or hepatocellular carcinoma in the setting of cirrhosis. Both conditions are associated with loss of skeletal muscle mass (sarcopenia) and physical deconditioning. Both conditions result in a dramatic decrease in the patients' quality of life, negatively impacting on the pre- and post-transplant prognosis. In this context, awareness of the advantages of physical activity in both the pre- and post-transplant setting is key...
October 16, 2018: Advances in Therapy
https://www.readbyqxmd.com/read/30324127/occult-hepatitis-b-virus-infection-an-old-entity-with-novel-clinical-involvements
#2
Vincenzo Malagnino, Djeneba Bocar Fofana, Karine Lacombe, Joel Gozlan
Background: Occult hepatitis B infection (OBI) is recognized as a risk factor for cirrhosis and hepato-cellular carcinoma. However, OBI brings together a large spectrum of patients who might harbor different characteristics and prognosis. Methods: We analyzed the databases of a university hospital in Paris to identify OBI among patients (n = 3966) concomitantly tested for hepatitis B virus (HBV) DNA and serology during a 7-year period. OBI patients were gathered into clinical entities according to their clinical records...
October 2018: Open Forum Infectious Diseases
https://www.readbyqxmd.com/read/30323642/d-dimer-plasmatic-levels-as-a-marker-for-diagnosis-and-prognosis-of-hepatocellular-carcinoma-patients-with-portal-vein-thrombosis
#3
Michele Malaguarnera, Saverio Latteri, Gaetano Bertino, Roberto Madeddu, Vito Emanuele Catania, Giuseppe Currò, Antonio Maria Borzì, Filippo Drago, Giulia Malaguarnera
Purpose: Portal vein thrombosis (PVT) is one of the severe complications of hepatocellular carcinoma (HCC). PVT deteriorates the liver, and its dysfunction increases the risk of bleeding, influencing the prognosis of patients with liver cirrhosis and HCC. The aim of our study was to investigate whether D-dimer testing could be a sensitive marker for the diagnosis and prognosis of HCC patients with PVT. Patients and methods: Between June 2010 and December 2015, 118 HCC patients were admitted to Cannizzaro Hospital, Catania, and 50 controls were recruited from their relatives for health examinations...
2018: Clinical and Experimental Gastroenterology
https://www.readbyqxmd.com/read/30314525/imaging-and-clinical-features-of-primary-hepatic-sarcomatous-carcinoma
#4
Dongli Shi, Liang Ma, Dawei Zhao, Jing Chang, Chen Shao, Shi Qi, Feng Chen, Yunfang Li, Xing Wang, Yanyan Zhang, Jing Zhao, Hongjun Li
BACKGROUND: Primary hepatic sarcomatous carcinoma (PHSC) is a rare malignancy composed of both carcinomatous (either hepatocellular or cholangiocellular) and sarcomatous components. The purpose of our study was to evaluate the imaging and clinical findings of PHSCs, improving the understanding and diagnosis of tumors. METHODS: We retrospectively reviewed the imaging and clinical findings of ten patients with pathologically proven PHSCs, including two cases of sarcomatous intrahepatic cholangiocarcinoma (S-ICC), seven cases of sarcomatous hepatocellular carcinoma (S-HCC) and one case of sarcomatous combined hepatocellular and cholangiocarcinoma (S-HCC-CC)...
October 12, 2018: Cancer Imaging: the Official Publication of the International Cancer Imaging Society
https://www.readbyqxmd.com/read/30312295/the-prognostic-value-of-prognostic-nutritional-index-in-hepatocellular-carcinoma-patients-a-meta-analysis-of-observational-studies
#5
Zhiling Wang, Jie Wang, Peijun Wang
BACKGROUND AND AIMS: The clinical value of the prognostic nutritional index (PNI) in hepatocellular carcinoma (HCC) has been investigated in previous studies, but the results remain controversial. Here we present a meta-analysis to systematically review the association between PNI and HCC prognosis. METHOD: PubMed, EMBASE, Web of Science databases were systematically searched to identify relevant studies. Data were abstracted independently by two reviewers. A meta-analysis was performed to determine the prognostic and clinic-pathological values of PNI in HCC patients...
2018: PloS One
https://www.readbyqxmd.com/read/30312023/role-of-micrornas-in-the-development-of-hepatocellular-carcinoma-in-nonalcoholic-fatty-liver-disease
#6
REVIEW
Cheng Zhang, Ping Wang, Yongqiang Li, Changxin Huang, Wei Ni, Yidan Chen, Junping Shi, Gongying Chen, Xiangrong Hu, Meng Ye, Shiwei Duan, Kaifeng Wang
Hepatocellular carcinoma (HCC) is a prevalent liver malignancy that can be developed from nonalcoholic fatty liver disease (NAFLD). Numerous pathophysiological alterations, including insulin resistance, specific cytokine release, oxidative stress and mitochondrial damage, are involved in the transition of NAFLD to cirrhosis and HCC. MicroRNAs, as post-transcriptional modulators, play a critical role in the pathogenesis of NAFLD-related HCC by regulating lipid metabolism, glucose homeostasis, cell proliferation, apoptosis, migration and differentiation...
October 12, 2018: Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology
https://www.readbyqxmd.com/read/30304545/dysregulation-of-ftx-mir-545-signaling-pathway-downregulates-tim-3-and-is-responsible-for-the-abnormal-activation-of-macrophage-in-cirrhosis
#7
Xia Liu, Cong Li, Jie Zhu, Wenshuai Li, Qiang Zhu
BACKGROUND: Accumulating evidence has suggested the involvement of miR-545 and long noncoding RNA (lncRNA) FTX in a wide range of diseases. Therefore, this study aimed to investigate the molecular mechanism underlying the function of miR-545 and lncRNA FTX in hepatitis B virus (HBV)-related cirrhosis. METHOD: The level of Tim-3, TLR-4, and endotoxin was detected in CD14+ , CD14 + CD16 + , and CD14 + CD16 - monocytes isolated from both patients with cirrhosis and healthy controls...
October 10, 2018: Journal of Cellular Biochemistry
https://www.readbyqxmd.com/read/30304523/expression-analysis-of-long-non-coding-rna-har1a-and-har1b-in-hbv-induced-hepatocullular-carcinoma-in-chinese-patients
#8
Zhenjing Shi, Ya Luo, Minghui Zhu, Yu Zhou, Bingru Zheng, Daoyi Wu, Shuting Wang, Xiangbang Xie, Heping Lin, Xixiang Yu
Objective: To determine the clinical relevance of long noncoding RNA (lncRNA) HAR1A and HAR1B expression in hepatocellular carcinoma (HCC). Methods: In this study, we enrolled 50 cases of chronic hepatitis B (CHB) without cirrhosis, 50 cases of CHB and liver cirrhosis (LC), and 100 cases of HBV and HCC. The expression profiles of lncRNA HAR1A and HAR1B were analyzed using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Results: The expression levels of HAR1A and HAR1B were significantly lower in the HCC group, compared with the CHB and LC groups (P <...
October 9, 2018: Laboratory Medicine
https://www.readbyqxmd.com/read/30302735/antifibrotics-in-liver-disease-are-we-getting-closer-to-clinical-use
#9
REVIEW
Meena B Bansal, Naichaya Chamroonkul
The process of wound healing in response to chronic liver injury leads to the development of liver fibrosis. Regardless of etiology, the profound impact of the degree of liver fibrosis on the prognosis of chronic liver diseases has been well demonstrated. While disease-specific therapy, such as treatments for viral hepatitis, has been shown to reverse liver fibrosis and cirrhosis in both clinical trials and real-life practice, subsets of patients do not demonstrate fibrosis regression. Moreover, where disease-specific therapies are not available, the need for antifibrotics exists...
October 9, 2018: Hepatology International
https://www.readbyqxmd.com/read/30293330/-guidelines-on-the-management-of-hepatic-encephalopathy-in-cirrhosis
#10
(no author information available yet)
The Chinese Society of Hepatology developed the current guidelines on the management of hepatic encephalopathy (HE) in cirrhosis based on the published evidences and panelists' consensus. The guidelines provided recommendations for the diagnosis and management of hepatic encephalopathy including minimal hepatic encephalopathy (MHE) and overt hepatic encephalopathy (OHE) emphasizing the importance on screening MHE in patients with end-stage liver diseases. The guidelines emphasized that early identification and prompt treatment are essential to improve the prognosis of HE...
October 1, 2018: Zhonghua Nei Ke za Zhi [Chinese Journal of Internal Medicine]
https://www.readbyqxmd.com/read/30292461/enhancement-patterns-of-intrahepatic-cholangiocarcinoma-on-contrast-enhanced-ultrasound-correlation-with-clinicopathologic-findings-and-prognosis
#11
Mengxia Yuan, Rui Li, Yingjie Zhang, Lin Yang, Xiaohang Zhang, Chunlin Tang, Deyu Guo
To evaluate the correlations between the enhancement pattern of intrahepatic cholangiocarcinoma (ICC) on contrast-enhanced ultrasound (CEUS) and clinicopathologic findings and prognosis, a retrospective study was performed on 197 patients with mass-forming ICC who underwent pre-operative CEUS and surgical resection. The contrast medium we employed in CEUS was SonoVue, which contains microbubbles consisting of sulfur hexafluoride bubbles within a phospholipid shell. This study was approved by the institutional review board with informed consent waived...
October 3, 2018: Ultrasound in Medicine & Biology
https://www.readbyqxmd.com/read/30288355/potentiating-cancer-vaccine-efficacy-in-liver-cancer
#12
Maria Tagliamonte, Annacarmen Petrizzo, Angela Mauriello, Maria Lina Tornesello, Franco M Buonaguro, Luigi Buonaguro
Hepatocellular carcinoma (HCC) is the most common liver malignancy with a poor prognosis and an overall 5-year survival rate of approximately 5-6%. This is due because standard of care treatment options are limited and none of them shows a sufficient efficacy. HCC is an "inflammation-induced cancer" and preliminary preclinical and clinical data suggest that immunotherapeutic approaches may be a good alternative candidate for the treatment of HCC patients improving the dismal prognosis associated with this cancer...
2018: Oncoimmunology
https://www.readbyqxmd.com/read/30286824/complications-of-cirrhosis-in-primary-care-recognition-and-management-of-hepatic-encephalopathy
#13
REVIEW
Steven L Flamm
Approximately 3.7% of patients in primary care settings have chronic liver disease, and 18% with chronic liver disease in the specialty care setting have cirrhosis. For cirrhotic patients without complications, prognosis is generally favorable; increased morbidity and mortality are observed when complications (i.e., hepatic encephalopathy [HE]) occur. HE occurs in up to 70% of patients with cirrhosis. Neurologic signs in HE span a wide spectrum, from those not easily apparent (covert) to more clinically obvious signs (overt)...
September 2018: American Journal of the Medical Sciences
https://www.readbyqxmd.com/read/30284991/clinicopathologic-characteristics-andoutcomes-of-hepatocellular-carcinoma-associated-with-chronic-hepatitis-b-versus-hepatitis-c-infection
#14
Abdulrahman A Aljumah, Hadi Kuriry, Nabiha Faisal, Hamdan Alghamdi
BACKGROUND: Hepatocellular carcinoma (HCC) is a primary liver malignancy and one of the most common cancers worldwide. Few studies in Saudi Arabia have compared the clinicopathologic characteristics of HCC caused by hepatitis B virus (HBV) versus hepatitis C virus (HCV) and their effect on patient survival and prognosis. OBJECTIVES: Identify differences in clinicopathological characteristics and outcomes of hepatocellular carcinoma (HCC) caused by HBV versus HCV...
September 2018: Annals of Saudi Medicine
https://www.readbyqxmd.com/read/30284699/impaired-renal-function-may-not-negate-the-efficacy-of-tolvaptan-in-the-treatment-of-cirrhotic-patients-with-refractory-ascites
#15
Yoshitaka Arase, Tatehiro Kagawa, Kota Tsuruya, Hirohiko Sato, Erika Teramura, Kazuya Anzai, Shunji Hirose, Ryuzo Deguchi, Koichi Shiraishi, Tetsuya Mine
BACKGROUND AND OBJECTIVE: Tolvaptan, an oral vasopressin V2 receptor antagonist, has been widely used for the treatment of patients with cirrhosis and ascites. However, its efficacy in patients with renal dysfunction remains unknown. The objective of this study was to investigate the efficacy and safety of tolvaptan in patients with decompensated cirrhosis and severe chronic kidney disease (s-CKD). METHODS: We studied 43 patients with liver cirrhosis who received tolvaptan (7...
October 4, 2018: Clinical Drug Investigation
https://www.readbyqxmd.com/read/30283499/rifaximin-has-the-potential-to-prevent-complications-of-cirrhosis
#16
Steven L Flamm, Kevin D Mullen, Zeev Heimanson, Arun J Sanyal
Background: Cirrhosis-related complications are associated with poor prognosis. With our analyses, we examined the potential benefit of rifaximin in reducing the risk of developing cirrhosis-related complications. Methods: Adults with cirrhosis and hepatic encephalopathy (HE) in remission were randomly assigned to receive rifaximin 550 mg twice daily or placebo for 6 months with concomitant lactulose permitted. Post hoc analyses examined time to cirrhosis-related complications (HE, spontaneous bacterial peritonitis (SBP), variceal bleeding, acute kidney injury/hepatorenal syndrome)...
2018: Therapeutic Advances in Gastroenterology
https://www.readbyqxmd.com/read/30279030/is-sarcopenia-associated-with-hepatic-encephalopathy-in-liver-cirrhosis-a-systematic-review-and-meta-analysis
#17
Ke-Vin Chang, Jin-De Chen, Wei-Ting Wu, Kuo-Chin Huang, Hong-Yi Lin, Der-Sheng Han
BACKGROUND/PURPOSE: Hepatic encephalopathy (HE), a major neuropsychiatric complication in advanced liver disease, is associated with poor prognosis. Sarcopenia, characterized by a decline in muscle mass, strength, and physical performance, is prevalent in liver cirrhosis. This study aims to explore whether sarcopenia is associated with HE in cirrhotic patients. METHODS: PubMed and EMBASE were searched for relevant cohort and case-control studies investigating the association between sarcopenia and HE up to July 2018...
September 29, 2018: Journal of the Formosan Medical Association, Taiwan Yi Zhi
https://www.readbyqxmd.com/read/30276961/applicability-of-sepsis-3-criteria-and-qsofa-in-patients-with-cirrhosis-hospitalized-for-bacterial-infections
#18
Fernanda Cristina de Augustinho, Tamara Liana Zocche, Ariane Borgonovo, Dariana Carla Maggi, Elayne Cristina de Morais Rateke, Camila Matiollo, Esther Buzaglo Dantas-Correa, Janaína Luz Narciso-Schiavon, Leonardo Lucca Schiavon
BACKGROUND AND AIMS: An algorithm including Sepsis-3 criteria and qSOFA was recently proposed to predict severity of infection in cirrhosis. However, its applicability among patients without a baseline SOFA available for Sepsis-3 definition is unknown. We sought to investigate the applicability and prognostic value of qSOFA and Sepsis-3 criteria in patients with cirrhosis hospitalized for bacterial infections, without pre-hospitalization SOFA. METHODS: In this cohort study, 164 patients were followed up to 30 days...
October 1, 2018: Liver International: Official Journal of the International Association for the Study of the Liver
https://www.readbyqxmd.com/read/30274686/hypoxia-inducible-factor-1%C3%AE-in-hepatocellular-carcinoma-with-cirrhosis-association-with-prognosis
#19
Dan Wang, Xiaojing Zhang, Yapeng Lu, Xueting Wang, Li Zhu
BACKGROUND: Hypoxia inducible factor 1α (HIF-1α) is a protein related with carcinogenesis and metastasis in many tumors. However, little is known about the prognostic value of HIF-1α in hepatocellular carcinoma (HCC) patients with cirrhosis. METHODS: Clinical-pathological information and follow-up data were collected from HCC (n = 419) and chronic hepatitis (n = 49) patients. HIF-1α expression was scored based on the percentage of immunohistochemical staining...
September 13, 2018: Pathology, Research and Practice
https://www.readbyqxmd.com/read/30272310/examining-the-key-genes-and-pathways-in-hepatocellular-carcinoma-development-from-hepatitis-b-virus%C3%A2-positive-cirrhosis
#20
Qi-Feng Chen, Jin-Guo Xia, Wang Li, Lu-Jun Shen, Tao Huang, Peihong Wu
To identify the key genes and pathways in the development of hepatocellular carcinoma (HCC) from hepatitis B virus (HBV)‑positive liver cirrhosis, differentially expressed genes (DEGs) between HCC and liver cirrhosis tissue samples from the GSE17548 gene expression profile dataset were screened. A total of 1,845 DEGs were identified, including 1,803 upregulated and 42 downregulated genes. Gene Ontology, Kyoto Encyclopedia of Genes and Genomes (KEGG) and protein‑protein interaction (PPI) network analyses were performed...
September 19, 2018: Molecular Medicine Reports
keyword
keyword
170509
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"